265 related articles for article (PubMed ID: 11836386)
1. Selection for c-myc integration sites in polyclonal T-cell lymphomas.
Broussard DR; Mertz JA; Lozano M; Dudley JP
J Virol; 2002 Mar; 76(5):2087-99. PubMed ID: 11836386
[TBL] [Abstract][Full Text] [Related]
2. The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas.
Rajan L; Broussard D; Lozano M; Lee CG; Kozak CA; Dudley JP
J Virol; 2000 Mar; 74(5):2466-71. PubMed ID: 10666282
[TBL] [Abstract][Full Text] [Related]
3. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
Mertz JA; Mustafa F; Meyers S; Dudley JP
J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
[TBL] [Abstract][Full Text] [Related]
4. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
5. The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis.
Mustafa F; Bhadra S; Johnston D; Lozano M; Dudley JP
J Virol; 2003 Mar; 77(6):3866-70. PubMed ID: 12610163
[TBL] [Abstract][Full Text] [Related]
6. Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomas.
DiFronzo NL; Frieder M; Loiler SA; Pham QN; Holland CA
J Virol; 2003 Mar; 77(5):3326-33. PubMed ID: 12584358
[TBL] [Abstract][Full Text] [Related]
7. ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.
Mertz JA; Kobayashi R; Dudley JP
J Virol; 2007 Apr; 81(7):3503-13. PubMed ID: 17229714
[TBL] [Abstract][Full Text] [Related]
8. Rorgamma (Rorc) is a common integration site in type B leukemogenic virus-induced T-cell lymphomas.
Broussard DR; Lozano MM; Dudley JP
J Virol; 2004 May; 78(9):4943-6. PubMed ID: 15078980
[TBL] [Abstract][Full Text] [Related]
9. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus.
Morrison HL; Soni B; Lenz J
J Virol; 1995 Jan; 69(1):446-55. PubMed ID: 7983741
[TBL] [Abstract][Full Text] [Related]
10. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
11. The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene.
Stewart M; MacKay N; Cameron ER; Neil JC
J Virol; 2002 May; 76(9):4364-9. PubMed ID: 11932403
[TBL] [Abstract][Full Text] [Related]
12. Conversion of mouse mammary tumor virus to a lymphomagenic virus.
Bhadra S; Lozano MM; Dudley JP
J Virol; 2005 Oct; 79(19):12592-6. PubMed ID: 16160187
[TBL] [Abstract][Full Text] [Related]
13. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
14. What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas.
Dudley JP; Mertz JA; Rajan L; Lozano M; Broussard DR
Leukemia; 2002 Jun; 16(6):1086-98. PubMed ID: 12040439
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.
Tsatsanis C; Fulton R; Nishigaki K; Tsujimoto H; Levy L; Terry A; Spandidos D; Onions D; Neil JC
J Virol; 1994 Dec; 68(12):8296-303. PubMed ID: 7966623
[TBL] [Abstract][Full Text] [Related]
16. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
[TBL] [Abstract][Full Text] [Related]
17. A common integration locus in type B retrovirus-induced thymic lymphomas.
Mueller RE; Baggio L; Kozak CA; Ball JK
Virology; 1992 Dec; 191(2):628-37. PubMed ID: 1333116
[TBL] [Abstract][Full Text] [Related]
18. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas.
Boerkoel CF; Kung HJ
J Virol; 1992 Aug; 66(8):4814-23. PubMed ID: 1321271
[TBL] [Abstract][Full Text] [Related]
20. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
Yanagawa S; Murakami A; Tanaka H
J Virol; 1990 Jun; 64(6):2474-83. PubMed ID: 2159524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
